Waxman Opposes Hatch Plan To Keep Generics Out Of PTAB
A proposal by one of the architects of the Hatch-Waxman Act to effectively bar generic-drug makers from challenging patents at the Patent Trial and Appeal Board has met opposition from the...To view the full article, register now.
Already a subscriber? Click here to view full article